<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01732185</url>
  </required_header>
  <id_info>
    <org_study_id>P100510</org_study_id>
    <nct_id>NCT01732185</nct_id>
  </id_info>
  <brief_title>Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations</brief_title>
  <acronym>MAKP</acronym>
  <official_title>Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to identify genetic abnormalities and molecular pathways associated
      with the occurrence of CCAM.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Congenital lung malformations are rare diseases, characterized by the coexistence in the same
      individual of normal lung and localized lung malformation. Among these malformations,
      congenital cystic adenomatoid malformations (CCAM) represent the most important group, with
      an estimated incidence between 1/11 000 and 1/35 000 births. The precise mechanisms leading
      to these lung malformations remain poorly understood. This project aims to identify key
      genetic and/or molecular mechanisms associated with the occurrence of CCAM. CCAMs are
      collected during postnatal surgical resection. Parental agreement is required. A standardised
      histologic description of malformations is performed for each sample. Normal lung tissue at
      the periphery of the malformation is considered as control. Malformations will be analyzed in
      a systematic way by proteome and transcriptome, after laser microdissection. Somatic genetic
      abnormalities will also systematically be sought.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mRNA expression</measure>
    <time_frame>at Day 0</time_frame>
    <description>Transcriptomic analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Protein expression</measure>
    <time_frame>at Day 0</time_frame>
    <description>Proteomic expression</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatic genetic abnormalities</measure>
    <time_frame>at Day 0</time_frame>
    <description>CGH array</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Congenital Cystic Adenomatoid Malformation (CCAM)</condition>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>congenital cystic adenomatoid malformations</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Patient</intervention_name>
    <description>Blood and histological samples will be done at day of the inclusion.</description>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children &lt; 8 years

          -  Thoracic surgery for congenital lung malformation

          -  Parental written consent

        Exclusion Criteria:

          -  Children &gt; 8 years

          -  Previous infection of the malformation

          -  Parental rebutal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Delacourt, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Necker-Enfants Malades Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Necker-Enfants Malades Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Kotecha S, Barbato A, Bush A, Claus F, Davenport M, Delacourt C, Deprest J, Eber E, Frenckner B, Greenough A, Nicholson AG, Antón-Pacheco JL, Midulla F. Antenatal and postnatal management of congenital cystic adenomatoid malformation. Paediatr Respir Rev. 2012 Sep;13(3):162-70; quiz 170-1. doi: 10.1016/j.prrv.2012.01.002. Epub 2012 Apr 25. Review.</citation>
    <PMID>22726873</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2012</study_first_submitted>
  <study_first_submitted_qc>November 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2012</study_first_posted>
  <last_update_submitted>December 15, 2015</last_update_submitted>
  <last_update_submitted_qc>December 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Congenital lung malformation</keyword>
  <keyword>Congenital Cystic Adenomatoid Malformation</keyword>
  <keyword>Cystic lung disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Cystic Adenomatoid Malformation of Lung, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

